ATE3638T1 - Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. - Google Patents

Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.

Info

Publication number
ATE3638T1
ATE3638T1 AT80870033T AT80870033T ATE3638T1 AT E3638 T1 ATE3638 T1 AT E3638T1 AT 80870033 T AT80870033 T AT 80870033T AT 80870033 T AT80870033 T AT 80870033T AT E3638 T1 ATE3638 T1 AT E3638T1
Authority
AT
Austria
Prior art keywords
aniline derivatives
sulfonyl
processes
production
group
Prior art date
Application number
AT80870033T
Other languages
English (en)
Inventor
Marcel Descamps
Charles Goldenberg
Original Assignee
Sanofi, Societe Anonyme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi, Societe Anonyme filed Critical Sanofi, Societe Anonyme
Application granted granted Critical
Publication of ATE3638T1 publication Critical patent/ATE3638T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
AT80870033T 1979-06-14 1980-06-10 Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung. ATE3638T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7915232A FR2459235A1 (fr) 1979-06-14 1979-06-14 Nouveaux derives de sulfonyl-aniline, leur procede de preparation et leur application therapeutique
EP80870033A EP0022118B1 (de) 1979-06-14 1980-06-10 Sulfonyl-anilin-Derivate, Verfahren zu ihrer Herstellung und ihre therapeutische Verwendung

Publications (1)

Publication Number Publication Date
ATE3638T1 true ATE3638T1 (de) 1983-06-15

Family

ID=9226608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80870033T ATE3638T1 (de) 1979-06-14 1980-06-10 Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.

Country Status (6)

Country Link
US (1) US4330542A (de)
EP (1) EP0022118B1 (de)
JP (1) JPS5632450A (de)
AT (1) ATE3638T1 (de)
DE (1) DE3063594D1 (de)
FR (1) FR2459235A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040122000A1 (en) * 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
DE3276313D1 (en) * 1981-09-24 1987-06-19 Beecham Wuelfing Gmbh & Co Kg Sulphonamides
JP2556722B2 (ja) * 1988-02-18 1996-11-20 興和株式会社 新規なスルホンアミド化合物
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2655652B1 (fr) * 1989-12-13 1994-06-10 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et les medicaments les contenant.
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US5783701A (en) 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
ATE184594T1 (de) * 1994-03-07 1999-10-15 Vertex Pharma Sulfonamidderivate als aspartylprotease- inhibitoren
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
US5883252A (en) * 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US6960579B1 (en) * 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
AU767728B2 (en) 1998-06-19 2003-11-20 Vertex Pharmaceuticals Incorporated Sulfonamide inhibitors of aspartyl protease
US20020155088A1 (en) * 2001-04-23 2002-10-24 Chiang Long Y. Tumor treatment by using oligoaniline
US8039514B2 (en) * 2008-06-05 2011-10-18 Asahi Kasei Pharma Corporation Sulfonamide compounds and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2575122A (en) * 1950-10-11 1951-11-13 Parke Davis & Co Piperazine compounds
JPS49101383A (de) * 1973-02-05 1974-09-25
SE403611B (sv) * 1975-09-05 1978-08-28 Berol Kemi Ab Forfarande for framstellning av en reaktionsprodukt mellan en epoxid och en organisk forening innehallande reaktivt vete i nervaro av viss angiven katalysator
DE2623314C2 (de) * 1976-05-25 1984-08-02 Hoechst Ag, 6230 Frankfurt 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
ES469020A1 (es) * 1977-05-10 1979-09-01 Kali Chemie Pharma Gmbh Procedimiento para la preparacion de nuevos 1-acil-2-hidroxi-1,3-diaminopropanos

Also Published As

Publication number Publication date
JPS5632450A (en) 1981-04-01
EP0022118A1 (de) 1981-01-07
US4330542A (en) 1982-05-18
FR2459235B1 (de) 1982-09-17
FR2459235A1 (fr) 1981-01-09
DE3063594D1 (en) 1983-07-07
EP0022118B1 (de) 1983-06-01

Similar Documents

Publication Publication Date Title
ATE3638T1 (de) Sulfonyl-anilin-derivate, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
SE8406585L (sv) Bensoesyraderivat
ATE50987T1 (de) Dihydropyridinderivate, deren herstellung und verwendung.
ATE15890T1 (de) Ein fungizides indanylbenzamid.
ATE21389T1 (de) Substituierte maleinsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
ATE112283T1 (de) Beta-d-phenylthioxyloside, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
ATE1625T1 (de) Isoxazolylcarbonsaeureanilide, ihre herstellung, diese enthaltende fungizide mittel und verfahren zur bekaempfung von pilzen.
ATE24509T1 (de) Triazoloquinazolone und deren salze, verfahren und zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
DE3668171D1 (de) 1-aryl-5-alkoximinoalkylamino-pyrazole.
ES8100796A1 (es) Un procedimiento para la preparacion de derivados de n-(fenilcicloalquil)acelamida
ES480391A1 (es) Un procedimiento para la preparacion de derivados de difeni-lamina.
ATE157648T1 (de) Imino-substituierte phenylessigsäureamide, ihre herstellung und diese enthaltende fungizide
ATE585T1 (de) N-azolylessigsaeureanilide, verfahren zu ihrer herstellung und ihre anwendung als herbizide.
ATE10370T1 (de) Benzothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung.
NO914577L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte piperazinoalkylbenzoksazin- og -tiazinforbindelser
JPS55141474A (en) Oxazoline and thiazoline derivative and manufacture
DK553482A (da) Fremgangsmaade til fremstilling af n,n-disubstituerede alkenamider og phenylalkenamider
ES8107183A1 (es) Procedimiento para la preparacion de derivados de amida de acido o-sulfamoilglicolico
MY103239A (en) A benzoylurea derivative and its production and use
ATE292T1 (de) Spiro-derivate von 3-(3,5 -dihalogenphenyl)-oxazolidin-2-thion-4-onen, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide.
ATE55599T1 (de) 3-amino-dihydropyridine, ein verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln.
ATE15887T1 (de) Substituierte phenyl-cyclopropancarbonsaeureester, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungs-mittel.
ATE71367T1 (de) Verfahren zur herstellung von indolinen.
CH653840GA3 (en) Process for protecting keratin-containing materials from attack by keratin-eating insects and 5-phenylcarbamoylbarbituric acid compounds
DE3565265D1 (de) Benzoyl ureas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee